相似文献
1
Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.
Infect Immun. 1979 Aug;25(2):771-3. doi: 10.1128/iai.25.2.771-773.1979.
2
Postimmunization clearance of liposome entrapped adenovirus type 5 hexon.
Proc Soc Exp Biol Med. 1982 Jan;169(1):135-9. doi: 10.3181/00379727-169-41321.
3
[Radioimmunological study of the antigenic determinants of human adenovirus 1 hexon].
Mikrobiol Zh (1978). 1982 May-Jun;44(3):51-6.
4
[Immunofluorescent study of the specificity of the hexon determinants in adenovirus-infected cells].
Mikrobiol Zh (1978). 1982 Sep-Oct;44(5):65-70.
5
[The N-terminal peptide of the hexon of human adenovirus type 2: its chemical synthesis and antigenic properties].
Mikrobiol Zh (1978). 1991 Sep-Oct;53(5):53-8.
6
Neutralizing antibodies to adenovirus serotype 5 vaccine vectors are directed primarily against the adenovirus hexon protein.
J Immunol. 2005 Jun 1;174(11):7179-85. doi: 10.4049/jimmunol.174.11.7179.
7
Analysis of adenovirus transforming proteins from early regions 1A and 1B with antisera to inducible fusion antigens produced in Escherichia coli.
J Virol. 1984 Jan;49(1):132-41. doi: 10.1128/JVI.49.1.132-141.1984.
8
Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
Virus Res. 2014 Apr;183:67-74. doi: 10.1016/j.virusres.2014.01.027. Epub 2014 Feb 8.
9
Humoral immune response to the capsid components of recombinant adenoviruses: routes of immunization modulate virus-induced Ig subclass shifts.
Eur J Immunol. 1997 Mar;27(3):653-9. doi: 10.1002/eji.1830270312.
10
Immunogenicity of recombinant adenovirus-respiratory syncytial virus vaccines with adenovirus types 4, 5, and 7 vectors in dogs and a chimpanzee.
J Infect Dis. 1992 Oct;166(4):769-75. doi: 10.1093/infdis/166.4.769.
引用本文的文献
1
Vaccine development for human mastadenovirus.
J Thorac Dis. 2018 Jul;10(Suppl 19):S2280-S2294. doi: 10.21037/jtd.2018.03.168.
2
Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.
Hum Gene Ther. 2013 Jun;24(6):595-603. doi: 10.1089/hum.2012.245.
3
Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.
Infect Immun. 1980 Dec;30(3):728-33. doi: 10.1128/iai.30.3.728-733.1980.
4
In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.
Infect Immun. 1982 Jun;36(3):1209-16. doi: 10.1128/iai.36.3.1209-1216.1982.
5
The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.
Clin Exp Immunol. 1984 Jun;56(3):509-14.
6
Immunization against experimental murine salmonellosis with liposome-associated O-antigen.
Infect Immun. 1985 Jun;48(3):658-63. doi: 10.1128/iai.48.3.658-663.1985.
本文引用的文献
1
IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.
Proc Soc Exp Biol Med. 1964 Oct;117:186-90. doi: 10.3181/00379727-117-29531.
2
PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.
Proc Soc Exp Biol Med. 1963 Oct;114:37-42. doi: 10.3181/00379727-114-28579.
3
Incorporation of lysozyme into liposomes. A model for structure-linked latency.
J Biol Chem. 1970 Jul 10;245(13):3295-301.
4
Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range.
Science. 1972 Nov 24;178(4063):871-2. doi: 10.1126/science.178.4063.871.
5
Crystallization of a second adenovirus protein (the fibre).
Nature. 1971 Apr 16;230(5294):456-7. doi: 10.1038/230456a0.
6
Crystallization of an adenovirus protein (the hexon).
Nature. 1968 Aug 31;219(5157):946-7. doi: 10.1038/219946a0.
7
Release of macromolecular markers (enzymes) from liposomes treated with antibody and complement. An attempt at correlation with electron microscopic observations.
Biochim Biophys Acta. 1973 Mar 16;298(2):158-79. doi: 10.1016/0005-2736(73)90347-7.
8
Preparation of liposomes and a spectrophotometric assay for release of trapped glucose marker.
Methods Enzymol. 1974;32:501-13. doi: 10.1016/0076-6879(74)32050-2.
9
Liposomes as immunological adjuvants.
Nature. 1974 Nov 15;252(5480):252. doi: 10.1038/252252a0.
10
Induction of immunity in man by crystalline adenovirus type 5 capsid antigens.
Proc Soc Exp Biol Med. 1973 Sep;143(4):905-10. doi: 10.3181/00379727-143-37438.
Zotero 插件